Wang Ting, Cauchon Nina S, Kirwan J Paul, Joubert Marisa K, Algorri Marquerita, Bell Brian, Soto Robert J, Semin David J
Process Development, Amgen Inc., Thousand Oaks, CA 91320, United States.
Global Regulatory Affairs and Strategy, Amgen Inc., Thousand Oaks, CA 91320, United States.
J Pharm Sci. 2025 Feb;114(2):816-828. doi: 10.1016/j.xphs.2024.12.025. Epub 2024 Dec 25.
Analytical technologies and methods play a pivotal role in attribute understanding and control which are essential to the rapidly evolving field of pharmaceutical development and manufacturing. These technologies are advancing quickly, where innovations often involve both new scientific approaches and novel applications of established techniques. In many cases, the lack of harmonized global regulatory expectations presents challenges for the adoption of advanced technologies. This review explores some emerging technology trends and applications, while highlighting regulatory considerations for integrating innovative analytical approaches in pharmaceutical manufacturing. We provide detailed examples on the multi-attribute method (MAM), rapid microbial testing for environmental monitoring, and Raman spectroscopy for product identification, while discussing aspects of the current regulatory landscape and desired future advancements in the regulatory framework. We hope to promote the adoption and implementation of innovative analytical technologies for enhanced patient access, while ensuring product quality and safety.
分析技术和方法在属性理解与控制方面发挥着关键作用,而属性理解与控制对于快速发展的药物研发与制造领域至关重要。这些技术正在迅速发展,创新往往涉及新的科学方法和现有技术的新颖应用。在许多情况下,全球监管期望缺乏协调性给先进技术的采用带来了挑战。本综述探讨了一些新兴技术趋势和应用,同时强调了在药物制造中整合创新分析方法的监管考量。我们提供了多属性方法(MAM)、环境监测的快速微生物检测以及产品识别的拉曼光谱的详细示例,同时讨论了当前监管格局的各个方面以及监管框架未来期望的进展。我们希望促进创新分析技术的采用和实施,以增加患者获得药物的机会,同时确保产品质量和安全。